NVAX Stock – Novavax Inc. stock underperforms Wednesday when compared to competitors despite daily gains
Shares of Novavax Inc.
advanced 2.25% to $212.83 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index
rising 1.19% to 13,950.22 and the Dow Jones Industrial Average
rising 0.93% to 34,137.31. The stock’s rise snapped a two-day losing streak. Novavax Inc. closed $118.85 short of its 52-week high ($331.68), which the company reached on February 9th.
The stock underperformed when compared to some of its competitors Wednesday, as Replimune Group Inc.
rose 4.14% to $29.68, VBI Vaccines Inc.
rose 7.66% to $2.81, and AnaptysBio Inc.
rose 3.51% to $22.68. Trading volume (2.4 M) remained 788,154 below its 50-day average volume of 3.2 M.